SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-12-045446
Filing Date
2012-08-14
Accepted
2012-08-14 16:21:51
Documents
1
Period of Report
2012-08-13

Document Format Files

Seq Description Document Type Size
1 LARSON INITIAL HOLDINGS rrd352862.html 3  
1 LARSON INITIAL HOLDINGS rrd352862.xml 3 2119
  Complete submission text file 0001181431-12-045446.txt   3522
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Issuer) CIK: 0001029142 (see all company filings)

IRS No.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O PDL BIOPHARMA 932 SOUTHWOOD BOULEVARD INCLINE VILLAGE NV 89451
Business Address
LARSON CHRISTINE R (Reporting) CIK: 0001270013 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-34207 | Film No.: 121033250